Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TYPE
1051
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $17.4M | 0.02% |
1,030,951
+24,400
| +2% | +$435K |
|
|
RVNC
1052
DELISTED
Revance Therapeutics, Inc.
RVNC
| $17.3M | 0.02% |
1,330,973
+428,900
| +48% | +$5.41M |
|
1053
Packaging Corp of America
PKG
$22.2B
| $17.3M | 0.02% |
+181,100
| New | +$17.5M |
|
1054
Wabash National
WNC
$504M
| $17.2M | 0.02% |
1,060,200
+391,900
| +59% | +$5.77M |
|
|
EVBG
1055
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $17.2M | 0.02% |
192,000
+67,500
| +54% | +$5.33M |
|
1056
International Paper
IP
$22.6B
| $17.1M | 0.02% |
417,965
+408,567
| +4,347% | +$17.3M |
|
1057
Insulet
PODD
$11.8B
| $17.1M | 0.02% |
+143,400
| New | +$14.7M |
|
|
STAY
1058
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $17.1M | 0.02% |
1,012,600
-74,600
| -7% | -$1.32M |
|
1059
Ethan Allen Interiors
ETD
$600M
| $17.1M | 0.02% |
810,300
-97,900
| -11% | -$2.06M |
|
1060
Mativ Holdings
MATV
$479M
| $17M | 0.02% |
512,600
+125,300
| +32% | +$4.24M |
|
1061
Wynn Resorts
WYNN
$10.3B
| $17M | 0.02% |
137,175
-335,625
| -71% | -$43.2M |
|
1062
Ezcorp Inc
EZPW
$1.79B
| $17M | 0.02% |
1,794,921
+554,121
| +45% | +$5.39M |
|
|
LEXEA
1063
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $17M | 0.02% |
355,600
+32,300
| +10% | +$1.43M |
|
1064
Great Southern Bancorp
GSBC
$878M
| $17M | 0.01% |
283,400
+5,000
| +2% | +$284K |
|
1065
Commercial Vehicle Group
CVGI
$147M
| $16.9M | 0.01% |
2,109,700
+279,300
| +15% | +$2.18M |
|
1066
Hubbell
HUBB
$24.4B
| $16.9M | 0.01% |
129,700
-65,700
| -34% | -$8.11M |
|
1067
MasterCraft Boat Holdings
MCFT
$596M
| $16.9M | 0.01% |
863,100
-189,800
| -18% | -$4.33M |
|
|
CHMI
1068
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
| $16.9M | 0.01% |
1,056,052
-236,448
| -18% | -$4.01M |
|
1069
IMAX
IMAX
$2.67B
| $16.9M | 0.01% |
835,600
+379,000
| +83% | +$8.55M |
|
|
GRP.U
1070
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $16.9M | 0.01% |
366,700
+6,353
| +2% | +$293K |
|
1071
AeroVironment
AVAV
$7.19B
| $16.8M | 0.01% |
296,336
+136,700
| +86% | +$9M |
|
1072
Ambarella
AMBA
$3.04B
| $16.8M | 0.01% |
380,000
+116,600
| +44% | +$5.22M |
|
1073
J.M. Smucker
SJM
$13.5B
| $16.7M | 0.01% |
+145,403
| New | +$17.8M |
|
1074
IDT Corp
IDT
$1.67B
| $16.7M | 0.01% |
1,765,406
+116,209
| +7% | +$856K |
|
1075
Peoples Bancorp
PEBO
$1.51B
| $16.7M | 0.01% |
518,179
-6,300
| -1% | -$201K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.